Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 885

1.

The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis.

Feki S, Gargouri S, Mejdoub S, Dammak M, Hachicha H, Hadiji O, Feki L, Hammami A, Mhiri C, Karray H, Masmoudi H.

J Neuroimmunol. 2018 Aug 15;321:66-71. doi: 10.1016/j.jneuroim.2018.05.015. Epub 2018 May 28.

PMID:
29957390
2.

Environmental exposures and the risk of multiple sclerosis in Saudi Arabia.

Al Wutayd O, Mohamed AG, Saeedi J, Al Otaibi H, Al Jumah M.

BMC Neurol. 2018 Jun 19;18(1):86. doi: 10.1186/s12883-018-1090-8.

3.

The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.

Hottenrott T, Schorb E, Fritsch K, Dersch R, Berger B, Huzly D, Rauer S, Tebartz van Elst L, Endres D, Stich O.

J Neurol. 2018 May;265(5):1106-1114. doi: 10.1007/s00415-018-8779-x. Epub 2018 Mar 6.

PMID:
29511863
4.

Humoral response to John Cunningham virus during pregnancy in multiple sclerosis.

Saraste M, Atula S, Hedman K, Hurme S, Jalkanen A, Sneck M, Surcel HM, Maghzi AH, Airas L.

Mult Scler Relat Disord. 2018 Apr;21:11-18. doi: 10.1016/j.msard.2018.02.008. Epub 2018 Feb 9.

5.

The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis.

Hottenrott T, Dersch R, Berger B, Endres D, Huzly D, Thiel J, Rauer S, Stich O, Salzer U, Venhoff N.

BMC Neurol. 2018 Jan 31;18(1):14. doi: 10.1186/s12883-018-1018-3.

6.

Do patients with schizophreniform and bipolar disorders show an intrathecal, polyspecific, antiviral immune response? A pilot study.

Endres D, Huzly D, Dersch R, Stich O, Berger B, Schuchardt F, Perlov E, Venhoff N, Hellwig S, Fiebich BL, Erny D, Hottenrott T, Tebartz van Elst L.

Fluids Barriers CNS. 2017 Dec 7;14(1):34. doi: 10.1186/s12987-017-0082-1.

7.

Enrichment of Retroviral Sequences in Brain Tissue from Patients with Severe Demyelinating Diseases.

Kriesel JD, Bhetariya PJ, Chan BK, Wilson T, Fischer KF.

J Emerg Dis Virol. 2017 Aug;3(2). doi: 10.16966/2473-1846.132. Epub 2017 Jul 16.

8.

Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.

Ruprecht K, Wildemann B, Jarius S.

J Neurol. 2018 Feb;265(2):239-252. doi: 10.1007/s00415-017-8656-z. Epub 2017 Nov 2. Review.

PMID:
29098417
9.

Vaccines to Children: Protective Effect and Adverse Events: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009 Feb.

10.

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.

Jarius S, König FB, Metz I, Ruprecht K, Paul F, Brück W, Wildemann B.

J Neuroinflammation. 2017 Aug 29;14(1):171. doi: 10.1186/s12974-017-0929-z.

12.

Multiple sclerosis and environmental risk factors: a case-control study in Iran.

Abbasi M, Nabavi SM, Fereshtehnejad SM, Jou NZ, Ansari I, Shayegannejad V, Mohammadianinejad SE, Farhoudi M, Noorian A, Razazian N, Abedini M, Faraji F.

Neurol Sci. 2017 Nov;38(11):1941-1951. doi: 10.1007/s10072-017-3080-9. Epub 2017 Aug 10.

PMID:
28799006
13.

Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.

Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM.

Acta Neurol Scand. 2017 Dec;136(6):606-616. doi: 10.1111/ane.12775. Epub 2017 May 23. Review.

PMID:
28542724
14.

The MRZ reaction in primary progressive multiple sclerosis.

Hottenrott T, Dersch R, Berger B, Rauer S, Huzly D, Stich O.

Fluids Barriers CNS. 2017 Feb 7;14(1):2. doi: 10.1186/s12987-016-0049-7.

15.

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Jarius S, Eichhorn P, Franciotta D, Petereit HF, Akman-Demir G, Wick M, Wildemann B.

J Neurol. 2017 Mar;264(3):453-466. doi: 10.1007/s00415-016-8360-4. Epub 2016 Dec 22. Review.

PMID:
28005176
16.

MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients.

Dias-Carneiro RP, von Glehn F, Moraes AS, Boldrini VO, Damasceno A, Andrade MD, Lima AC, Casanova CS, Tilbery CP, Damasceno BP, Santos LM, Brandão CO.

J Neuroimmunol. 2016 Nov 15;300:30-35. doi: 10.1016/j.jneuroim.2016.10.001. Epub 2016 Oct 5.

PMID:
27806873
17.

Correlation between anti-JC-virus and anti-cytomegalovirus, -Epstein-Barr virus and -measles/-rubella/-varicella-zoster-virus antibodies.

Auer M, Borena W, Holm-von Laer D, Deisenhammer F.

J Med Virol. 2017 Jan;89(1):3-9. doi: 10.1002/jmv.24590. Epub 2016 Jun 9.

PMID:
27253624
18.

Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosis.

Huss A, Buttmann M, Brecht I, Weishaupt A, Otto M, Tumani H.

Expert Rev Mol Diagn. 2016 Dec;16(12):1353-1356. Epub 2016 Oct 31.

PMID:
27759441
19.

Vaccines and multiple sclerosis: a systematic review.

Mailand MT, Frederiksen JL.

J Neurol. 2017 Jun;264(6):1035-1050. doi: 10.1007/s00415-016-8263-4. Epub 2016 Sep 7. Review.

PMID:
27604618
20.

Frequency of viral infections and environmental factors in multiple sclerosis.

Eftekharian MM, Ghannad MS, Taheri M, Roshanaei G, Mazdeh M, Musavi M, Hormoz MB.

Hum Antibodies. 2016 Jun 8;24(1-2):17-23. doi: 10.3233/HAB-150289.

PMID:
27472869

Supplemental Content

Loading ...
Support Center